Members of Fish & Richardson's litigation group in Dallas racked up a series of impressive wins for plaintiffs and defendants during the 15-month period beginning in January 2012.
The Fish litigators started 2012 by securing a $158 million settlement with Johnson & Johnson subsidiary Janssen in a case it worked on with the Texas Office of the Attorney General (OAG). The settlement came after approximately a week of trial in State of Texas ex rel. Jones v. Janssen LP, et al.,a civil Medicaid fraud case involving allegations about Janssen's marketing of the antipsychotic drug Risperdal to the Texas Medicaid program for use by children.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
